Dashboard / Index chart

Nifty Pharma

Daily OHLC history, trend, risk, returns, and index valuation from NSE archives.

26,478.1

-0.7% latest completed session

1M return

-0.3%

3M return

+9.1%

6M return

+15.3%

1Y return

+20.8%

Combined leadership read · through 04 Sept 2026

Uptrend with relative leadership

Nifty Pharma remains above its 50-day and 200-day averages and is outperforming Nifty 50, without a fresh price-channel breakout.

Price

Inside channel

vs Nifty 50

Outperforming

Price Trend

249 daily sessions · latest 04 Sept 2026

3M 6M 1Y 3Y

Index chartsNifty 50 Next 50 Nifty 100 Nifty 500 Bank Nifty Midcap 150 Smallcap 250 Nifty IT

All indices

Nifty Pharma daily price

249 observations

04 Sept 2026O 26,659.55H 26,695L 26,461.4C 26,478.1-0.68%

Nifty Pharma26.5k

SMA 50

SMA 200

Trend & Risk Context

Price regime uses daily closes; volatility and drawdown use the selected 1Y window.

Trend regime

Above both

From 52W high

-2.6%

52W position

88.2%

Annualised vol

13.6%

1Y max drawdown

−7.5%

50 / 200 DMA

26,193 / 23,809

Breakout, Support & Resistance

Prior-session Donchian levels with ATR-based price confirmation.

Inside channel

20D support

26,159

20D resistance

27,188

Gap above support

1.2%

Gap to resistance

2.7% below

ATR 14

284

20D channel position

31.0%

50-session channel: 24,948 support and 27,188 resistance. Confirmation is price-only because NSE index archives do not provide dependable index volume. Completed-session analysis through 04 Sept 2026; levels are context, not forecasts or trade calls.

Relative Strength vs Nifty 50

Close-to-close ratio rebased to 100 at the start of the selected window.

Outperforming

1M relative return

+2.7%

3M relative return

+6.7%

20-session momentum

+2.6%

From prior 63D high

-1.9%

Nifty Pharma relative-strength ratio

249 observations

04 Sept 2026Value 125.03-0.78%

Nifty Pharma / Nifty 50125.03

SMA 50

A rising ratio means Nifty Pharma is outperforming Nifty 50; a falling ratio means it is lagging. Relative strength is confirmation, not a standalone buy or sell signal.

Index Valuation History

Nifty Pharma valuation versus its own trailing history.

NSE archive source

Price to earnings · latest 41.00x

Higher than 91% of one-year observations

P/E daily history

248 observations

04 Sept 2026Value 41-0.68%

P/E41.00

Historical percentile is context, not a buy or sell threshold. Read P/E, P/B, and yield together with earnings, rates, and market regime.

Open Scanner

Find stocks aligned with this market move

Sector Heatmap

Compare U-Score quality by sector

Back to Dashboard

Return to Market Pulse